[ET Net News Agency, 31 January 2024] REMEGEN (09995) fell 10.2% to HK$15.42.
It hits an intra-day low of HK$15.42, hitting a historical low, and an intra-day high of
HK$17. The total shares traded was 3.98 million, with a value of HK$64.34m. The active
buy/sell ratio is 36:64, with net selling turnover of HK$17.6m. J.P. MORGAN BRO (HK)
accounts for greatest net responsive buying turnover of HK$7.31m, with volume weighted
average price of HK$16.156. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$6.94m, with volume weighted average price of HK$16.106.
The stock has fallen a combined 28.4% over the past 5 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 15.420 % Chg -10.24%
High 17.000 Low 15.420
Shares Tr 3.98m Turnover 64.34m
10-D SMA 20.556 %H.V 118.334
20-D SMA 26.413 VWAP 16.173
50-D SMA 34.288 RSI14 19.118
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 36:64, with net selling
turnover of HK$17.6m, falling a combined 28.4% over the past 5 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 15.42 -10.24
HUTCHMED (00013) 19.86 -0.95
GENSCRIPT BIO (01548) 12.96 -4.71
INNOVENT BIO (01801) 31.40 -1.41
KEYMED BIO-B (02162) 30.75 -3.76
WUXI XDC (02268) 19.20 -12.33
WUXI BIO (02269) 20.40 -8.72
TIGERMED (03347) 24.25 -7.27
BEIGENE (06160) 89.45 -4.74
AKESO (09926) 39.20 -1.38
---------------------------------------------
(ed)